The agreement was for the shares that were worth 4
Post# of 56323
GrowLife will issue to designated CEN Biotech shareholders a total of 235,294,118 shares of restricted GrowLife common stock, the equivalent of $40 million at $0.17 per share, after CEN Biotech is formally approved to produce and harvest cannabis by the appropriate Canadian authorities.
My take is they will use some of these shares to pay Growlife back all of the money they owe them including the $100 million.
Many of us are interested in that word designated ???